A recent inspection by India's drug regulator has revealed a troubling statistic: 167 medication samples were classified as not of standard quality (NSQ) in December, with valuable insights from both central and state laboratories aiding the findings. Many of these samples consisted of widely used drugs, highlighting a critical need for heightened quality control.
